Structural determinants for histamine H1 affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs
Authors:
- 11 July 2009
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (17) , 5043-5047
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studiesBioorganic & Medicinal Chemistry, 2006
- Characterization of a hERG Screen Using the IonWorks HT: Comparison to a hERG Rubidium Efflux ScreenASSAY and Drug Development Technologies, 2005
- QT prolongation in anaesthetized guinea‐pigs: an experimental approach for preliminary screening of torsadogenicity of drugs and drug candidatesJournal of Applied Toxicology, 2004
- Mutational analysis of the histamine H1-receptor binding pocket of histaprodifensEuropean Journal of Pharmacology, 2004
- Physicochemical Features of the hERG Channel Drug Binding SiteJournal of Biological Chemistry, 2004
- Development and Evaluation of High Throughput Functional Assay Methods for hERG Potassium ChannelSLAS Discovery, 2001
- Mutational Analysis of the Antagonist-binding Site of the Histamine H1 ReceptorJournal of Biological Chemistry, 1999
- Second-generation antihistamines: The risk of ventricular arrhythmiasClinical Therapeutics, 1999
- Antihistamine activity, central nervous system and cardiovascular profiles of histamine H1 antagonists: comparative studies with loratadine, terfenadine and sedating antihistamines in guinea‐pigsClinical & Experimental Allergy, 1995
- Site-Directed Mutagenesis of the Histamine H1 Receptor: Roles of Aspartic Acid107, Asparagine198 and Threonine194Biochemical and Biophysical Research Communications, 1994